PUBLISHER: The Insight Partners | PRODUCT CODE: 2165901
PUBLISHER: The Insight Partners | PRODUCT CODE: 2165901
The Europe Impulse Oscillometry Market is projected to reach US$ 39,359.3 Thousand by 2034, increasing from US$ 23,461.1 Thousand in 2025. The market is anticipated to register a CAGR of 6.0% during 2026-2034.
Executive Summary and Europe Impulse Oscillometry Market Analysis:
The Europe impulse oscillometry market, covering the UK, Germany, France, Italy, Spain, and the Rest of Europe, is expanding due to the increasing prevalence of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD), which is creating greater demand for advanced pulmonary diagnostic technologies beyond conventional spirometry. Impulse oscillometry provides effort-independent respiratory testing and can identify small-airway abnormalities while measuring airway resistance and reactance during normal tidal breathing. These characteristics make IOS particularly valuable for pediatric, elderly, and physically frail patients who may have difficulty performing traditional pulmonary function tests. The development of compact, easy-to-use IOS systems with digital connectivity is supporting adoption across hospitals, specialist respiratory clinics, and home healthcare environments. In addition, European healthcare systems are increasingly emphasizing preventive medicine, early diagnosis, and digitally enabled care, strengthening demand for sophisticated respiratory assessment technologies. The region's aging population is also contributing to a higher incidence of chronic respiratory conditions and supporting the use of lung function testing solutions. Growing clinical recognition of IOS, particularly its ability to identify early airway abnormalities and complement spirometry, is encouraging its integration into routine respiratory evaluation.
Strategic Insights
Europe Impulse Oscillometry Market Segmentation Analysis:
By Product, the Europe Impulse Oscillometry Market is categorized into Device and Accessories. The Device segment dominated the market in 2025.
By Device for Product, the market is divided into Desktop and Portable. The Desktop segment held the leading position in 2025.
By Accessories for Product, the market is segmented into Filters, Nose Clip, Support Arms, and Other Accessories. The Filters segment dominated the market in 2025.
By Application, the Europe Impulse Oscillometry Market is segmented into Asthma, COPD, and Other Applications. The Asthma segment accounted for the largest share in 2025.
By End User, the market includes Hospitals and Clinics, Diagnostic Laboratories, and Other End Users. The Hospitals and Clinics segment dominated the market in 2025.
Market Report Scope
Europe Impulse Oscillometry Market Outlook
Technological advancements in impulse oscillometry systems are improving the accuracy, convenience, and clinical applicability of respiratory diagnostics. Modern IOS platforms based on forced oscillation techniques and sophisticated signal-processing capabilities can analyze respiratory data in real time while requiring minimal effort from patients. For example, systems such as the Tremoflo C-100 from THORASYS use airway oscillometry to evaluate lung impedance during normal breathing. Digital interfaces and Bluetooth connectivity also facilitate the transfer of test results into electronic health records, streamlining clinical workflows. European Respiratory Society recommendations have highlighted improvements in IOS software and artifact-correction algorithms, which contribute to greater diagnostic consistency. Portable systems such as the Resmon Pro from RESTECH use miniaturized components, including microelectromechanical systems (MEMS), enabling pulmonary assessments in home and remote-care environments. This portability is particularly advantageous for monitoring chronic respiratory conditions and assessing patients who have difficulty completing conventional spirometry.
Further innovation in sensor technology, including the use of piezoelectric transducers capable of supporting higher frequency measurements, is enabling more detailed evaluation of small-airway function. Battery-operated and wireless configurations are also improving mobility and usability, particularly in pediatric and geriatric care. Hybrid platforms that combine IOS with technologies such as capnography or plethysmography can provide more comprehensive assessments of pulmonary function. At the same time, integration with telemedicine platforms is expanding the potential for remote respiratory monitoring. Standardized calibration approaches and phantom-based testing help improve reproducibility while supporting compliance with applicable medical-device standards. Together, these developments are increasing the versatility of IOS and strengthening its position as an important technology within modern respiratory diagnostics.
Europe Impulse Oscillometry Market Country Insights
By country, the Europe Impulse Oscillometry Market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. Germany held the largest market share in 2025.
Germany has a substantial respiratory disease burden, supporting the need for advanced pulmonary assessment technologies such as impulse oscillometry. According to the Robert Koch Institute's Journal of Health Monitoring, bronchial asthma prevalence in Germany was estimated at approximately 9%, affecting millions of individuals and contributing to healthcare utilization and reduced quality of life among both children and adults. The RKI has also reported an annual COPD prevalence of approximately 5.8% in Germany. COPD continues to contribute significantly to hospitalizations and mortality, particularly among older populations. As an effort-independent and noninvasive technique, IOS provides an alternative or complementary approach to spirometry for assessing small-airway function and identifying respiratory abnormalities in patients who have difficulty performing forced respiratory maneuvers.
Germany's aging demographic further supports the adoption of IOS. Data from Destatis indicate that approximately 19 million people aged 65 years and above were living in Germany in 2024, representing around 22.3% of the country's population. This demographic trend increases the need for respiratory diagnostic approaches that can be performed with minimal patient effort. European respiratory-care recommendations have also supported the use of IOS in pulmonary assessment, including applications involving asthma-COPD overlap and other respiratory conditions. These factors are contributing to the increasing integration of impulse oscillometry into German respiratory clinics and diagnostic workflows.
Europe Impulse Oscillometry Market Company Profiles
Major companies operating in the Europe Impulse Oscillometry Market include COSMED Srl, Chest MI Inc, Morgan Scientific Inc, THORASYS Thoracic Medical Systems Inc., Jaeger Medical GmbH, GANSHORN Medizin Electronic GmbH, Vitalograph Ltd, Lothar Medical GmbH, Cognita Labs, LLC, and RESTECH srl.
These market participants are implementing strategies including business expansion, product development, technological innovation, strategic collaborations, and mergers and acquisitions to introduce advanced respiratory diagnostic solutions, strengthen their product portfolios, and expand their market presence.